Vaginal mesh vs native tissue repairs for prolapse: FDA update and recent evidence

摘要

In 2010, 300,000 surgeries were performed in the U.S. for pelvic organ prolapse (POP), and 100,000 of those involved the placement of surgical mesh. The use of mesh in abdominal surgeries for POP has been described for over 50 years, but the first surgical mesh product specifically for POP was approved by the FDA in 2002. Over the last decade, transvaginal mesh POP surgeries have become more common, and mesh its?have been approved and are increasingly used for transvaginal POP repair, but clinical trial evidence of their safety and effectiveness has lagged behind rapid adoption into practice.